Overall, the findings from these two recently completed cardiovascular outcomes trials suggest that the increases in HR associated with the short-acting GLP-1 RA, lixisenatide, or the long-acting GLP-1 RA, liraglutide, do not lead to an increased risk of major adverse cardiac events in patients with T2DM and high cardiovascular risk
Secondary improvements, such as better sleep, higher energy, and improved mood, often show up alongside the physical changes
In the five SUSTAIN efficacy trials, semaglutide reduced hemoglobin A1c by 1.5 to 1.8 percentage points
That is why so many people look into it when they want a stronger level of support around weight loss and day-to-day consistency
Compounded Semaglutide and Tirzepatide: What FDA Status Actually Means for You This section matters more than almost any other in this article - because the FDA status of compounded medications is the one thing most buyers don't fully understand going in, and it's the thing with the most practical consequences for your purchase decision
By no means is this an attempt to suede or convince anyone of any ideology